Navigation Links
PULSin Protein & Antibody Delivery Reagent from Polyplus Transfection

ProductsPULSin Protein & Antibody Delivery Reagent from Polyplus Transfection
Company Polyplus Transfection
Item PULSin Protein & Antibody Delivery Reagent
Price $250.00
Description Protein/antibody delivery using PULSin may be superior to transfection in some applications. For example, unlike traditional transfection, with PULSin you can study lethal proteins and control the level and time course of proteins in cells. Likewise, delivery of blocking antibodies may provide more information than traditional RNA interference experiments.

With PULSin you can target intracellular proteins in living cells with antibodies without fixation, eliminating the time and effort of fixing cells.

PULSin contains a proprietary cationic lipid that noncovalently complexes with many proteins including antibodies. Complexes are internalized via anionic cell-adhesion receptors present on all cells and are released into the cytoplasm where they disassemble. The process is general, nontoxic and delivers unmodified, functional proteins.
Info Polyplus TransfectionPolyplus Transfection
310 S. Twin Oaks Valley Drive
Suite 107-180
San Marcos, CA 92078
Customer Service: (760) 481-4918
Web Site: http://www.polyplus-transfection.com/EN/index.php
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. PULSin Protein & Antibody Delivery Reagent from Polyplus Transfection
2. PULSin Protein & Antibody Delivery Reagent from Polyplus Transfection
3. Mouse Anti-Protein S Monoclonal Antibody, Unconjugated, Clone HYB 232-02 from Abcam
4. S-Protein Agarose from Novagen
5. Rabbit Anti-Human Vitamin K-dependent Protein S (PROS1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
6. S-Protein Agarose from Novagen
7. S-Protein Agarose from Novagen
8. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
9. Protein 295 ex from HORIBA Jobin Yvon
10. ProteomeLab PA 800 Protein Characterization System from Beckman Coulter
11. ProteomeLab PF 2D Protein Fractionation System from Beckman Coulter
... Neogens enzyme-linked immunosorbent assay (ELISA) test ... screening devices for the detection of drugs ... kits are intended for forensic use only. ... be confirmed by a quantitative method such ...
Cag-A (IgG) -Ab EIA Sample Size: 10 l...
... SUPERaseIn RNase Inhibitor (patent pending) is a ... noncovalently binds and inhibits the most common ... C, 1 and T1. SUPERaseIn can be ... could be problematic. It is ideal for ...
... human protein produced in E. coli and is ... type enzymes. The mode of inhibition is ... 1:1 ratio. The enzyme has been shown to ... types. Addition of the ribonuclease inhibitor has been ...
Biology Products:
(Date:1/3/2017)... VEGAS , Jan. 3, 2017 Onitor, ... the introduction of Onitor Track, an innovative biometric data-driven ... men, showcasing this month at the 2017 Consumer Electronics ... In the U.S., the World Health ... more than two-thirds of adults who are overweight or ...
(Date:12/20/2016)... 20, 2016   Valencell , the leading ... STMicroelectronics (NYSE: STM), a global semiconductor leader ... announced today the launch of a new, highly ... that includes ST,s compact SensorTile turnkey ... biometric sensor system. Together, SensorTile and Benchmark deliver ...
(Date:12/16/2016)... The global wearable medical device market, in terms of ... USD 5.31 billion in 2016, at a CAGR of 18.0% during ... ... in medical devices, launch of a growing number of smartphone-based healthcare ... healthcare providers, and increasing focus on physical fitness. ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... , January 20, 2017 ... is one of leading causes of death worldwide. There ... the number of cancer related deaths increased gradually over ... in incidence rate of various cancers continues to drive ... research report by Global Market Insights, Inc. cancer biological ...
(Date:1/19/2017)... Research Future has a half cooked research report on Global Liquid ... and expected to reach USD 450 Million by the end of ... ... assessed as a swiftly growing market and expected that the market ... There has been a tremendous growth in the prevalence of cancer ...
(Date:1/19/2017)... and Markets ... addition of the "Implantable Biomaterials Market Analysis & ... to their offering. Report Highlights: ... current and future market trends to identify the investment opportunities ... numbers Key market trends across the business segments, Regions ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 /PRNewswire/ ... a privately-held immunotherapeutics company targeting infectious diseases, announced ... the merger of PharmAthene and Altimmune in an ... Fund, HealthCap, Truffle Capital and Redmont Capital. The ... immunotherapeutics company with four clinical stage and one ...
Breaking Biology Technology: